直肠癌R1切除后IOERT与HDR-IORT的肿瘤学结局比较
本研究比较了局部进展期或局部复发直肠癌(LARC/LRRC)R1切除后接受术中电子束放疗(IOERT)或高剂量率术中近距离放疗(HDR-IORT)的肿瘤学结局。多因素分析显示两种方式总生存无显著差异,但HDR-IORT组无局部复发生存显著更长(LARC HR 0.496,LRRC HR 0.567)。LRRC患者HDR-IORT术后主要并发症发生率更高(46% vs 26%)。
要点
- R1切除的LARC/LRRC患者中,HDR-IORT较IOERT显著延长无局部复发生存。
- 两种IORT方式的总生存无显著差异。
- LRRC患者HDR-IORT术后主要并发症发生率高于IOERT(46% vs 26%)。
核心结论
- 在LARC或LRRC行R1切除的患者中,HDR-IORT较IOERT显著改善无局部复发生存,总生存无显著差异。
研究设计与样本
- 回顾性队列研究,纳入2000至2016年两家三级转诊中心因LARC或LRRC R1切除接受IORT的连续患者。
- LARC共215例(IOERT 151例,HDR-IORT 64例),LRRC共158例(IOERT 112例,HDR-IORT 46例)。
- LARC中切缘≤2 mm定义为R1,LRRC中切缘0 mm定义为R1。
主要发现
- 多因素分析显示两种IORT方式总生存无显著差异。
- LARC患者主要术后并发症两组相似(IOERT 30%,HDR-IORT 27%)。
- LRRC患者HDR-IORT组主要术后并发症发生率更高(IOERT 26%,HDR-IORT 46%)。
关键数值与推荐
- LARC:切缘≤2 mm定义为R1;LRRC:切缘0 mm定义为R1。
- LARC主要并发症:IOERT 30%,HDR-IORT 27%。
- LRRC主要并发症:IOERT 26%,HDR-IORT 46%。
临床怎么用
- 对于LARC或LRRC行R1切除的患者,可优先考虑HDR-IORT以改善局部控制。
- 选择HDR-IORT时需权衡LRRC患者更高的主要术后并发症风险。
- IOERT技术优化可能有助于缩小其与HDR-IORT在局部控制上的差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Intraoperative radiation therapy (IORT), delivered by intraoperative electron beam radiation therapy (IOERT) or high-dose-rate intraoperative brachytherapy (HDR-IORT), may reduce the local recurrence rate in patients with locally advanced and locally recurrent rectal cancer (LARC and LRRC, respectively). The aim of this study was to compare the oncological outcomes between both IORT modalities in patients with LARC or LRRC who underwent a microscopic irradical (R1) resection. METHODS: All consecutive patients who received IORT because of an R1 resection of LARC or LRRC between 2000 and 2016 in two tertiary referral centers were included. In LARC, a resection margin of ≤2 mm was considered R1. A resection margin of 0 mm was considered R1 in LRRC. RESULTS: In total, 215 patients with LARC were included, of whom 151 (70%) received IOERT and 64 (30%) received HDR-IORT; in addition, 158 patients with LRRC were included, of whom 112 (71%) received IOERT and 46 (29%) received HDR-IORT. After multivariable analyses, the overall survival was not significantly different between the two IORT modalities. The local recurrence-free survival was significantly longer in patients treated with HDR-IORT, both in LARC (hazard ratio [HR], 0.496; 95% CI, 0.253-0.973; P = .041) and LRRC (HR, 0.567; 95% CI, 0.349-0.920; P = .021). In patients with LARC, major postoperative complications were similar for both IORT modalities (IOERT, 30%; HDR-IORT, 27%), whereas in patients with LRRC, the incidence of major postoperative complications was higher after HDR-IORT (IOERT, 26%; HDR-IORT, 46%). CONCLUSIONS: This study showed a significantly better local recurrence-free survival in favor of HDR-IORT in patients with an R1 resection for LARC or LRRC. Optimization of the IOERT technique seems warranted.
引用
- Voogt ELK, van Rees JM, Hagemans JAW, et al. Intraoperative Electron Beam Radiation Therapy (IOERT) Versus High-Dose-Rate Intraoperative Brachytherapy (HDR-IORT) in Patients With an R1 Resection for Locally Advanced or Locally Recurrent Rectal Cancer. Int J Radiat Oncol Biol Phys. 2021. PMID: 33567303. doi:10.1016/j.ijrobp.2021.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。